MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy

PURPOSE: Identifying the temporal pattern of recurrence and prognostic biomarkers would further help improve the efficacy of chimeric antigen receptor (CAR) -T therapy. METHODS: We examined the prognoses of 119 patients after sequential infusion of anti-CD19 and anti-CD22, a cocktail of 2 single-tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jin, Liu, Tianjiao, Cheng, Jiali, Meng, Jiao, Wang, Na, Huang, Liang, Zhou, Xiaoxi, Chen, Liting, Luo, Hui, Zhou, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264474/
https://www.ncbi.nlm.nih.gov/pubmed/36869895
http://dx.doi.org/10.1007/s00262-023-03418-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264474/
https://www.ncbi.nlm.nih.gov/pubmed/36869895
http://dx.doi.org/10.1007/s00262-023-03418-2

Ejemplares similares